JUN 03, 2017 4:40 PM PDT

"Deprescribing" Cholesterol Drugs for Patients Nearing End of Life

WRITTEN BY: Kara Marker

Scientists from Oregon State University are testing the waters for people with “life-limiting” illnesses such as cancer and heart disease who might feel comfortable going off of medications they take to manage cholesterol, a process researchers are now calling “deprescribing.”

Credit: Medical News Today

Oregon State scientists believe that deprescribing statins originally prescribed to regulate cholesterol levels could improve health outcomes for people nearing the end of their life, a time where enhancing quality of life is more important than ever.

Statins are able to reduce levels of cholesterol by blocking the liver enzymes that produce it. This reduction prevents plaque buildup on the lining of blood vessels that contributes to atherosclerosis, stroke, or heart attack. However, these drugs are also infamous for side effects like muscle pain, digestive problems, and “mental fuzziness.”

"There's a lot of concern that patients will feel like doctors are giving up on them if they start to discontinue some of their medications, that there's something comforting about continuing to take their medications, and this gives us some indication of what patients feel about the risks and benefits of deprescribing,” study researcher Jon Furuno explained. The research team provided a questionnaire for study participants to express their concerns.

There were nearly 300 people overall enrolled in the recent Oregon State study, with an average age of 72 and life expectancy of less than one year. A large majority were cancer patients, and some had heart disease or other life-limiting disease. The study aimed to analyze the safety and effects of deprescribing stains by taking some participants off of the drug and some continue the drug. Despite Furuno’s concerns, less than five percent of the participants were actually concerned about being taking off of their statins, in fact, they seemed optimistic about what taking less drugs could do for their quality of life.

"Hopefully this will help inform prescribers who might be tentative to address this topic with their patients," Furuno said about the study. "As a patient's prognosis changes and we think they have a relatively short lifespan left, it really requires risk/benefit re-examination of everything we're doing for them, medications and everything else. There may still be benefits, but have the benefits changed or has the risk/benefit ratio changed?”

Furuno’s study was published in the Journal of Palliative Medicine.

Sources: Oregon State University, Mayo Clinic

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
DEC 23, 2020
Immunology
COVID Survivors Stay Immune for at Least a Year
DEC 23, 2020
COVID Survivors Stay Immune for at Least a Year
Once the coronavirus enters the body, the immune system springs into action, producing antibodies that bind to and neutr ...
DEC 27, 2020
Drug Discovery & Development
Attacking Mitochondria in Tumors
DEC 27, 2020
Attacking Mitochondria in Tumors
Researchers found that attacking a cell’s mitochondria can starve cancer cells. The study involves a possible ther ...
JAN 03, 2021
Genetics & Genomics
Exploiting Genetic Vulnerabilities in Cancer Cells
JAN 03, 2021
Exploiting Genetic Vulnerabilities in Cancer Cells
Genetic errors can drive cancer, often when critical genes like those that control cell division and proliferation becom ...
JAN 09, 2021
Drug Discovery & Development
Anticoagulant Drugs Prevent Cancer Spreading to Brain
JAN 09, 2021
Anticoagulant Drugs Prevent Cancer Spreading to Brain
Researchers from the Heidelberg University in Germany have found that anticoagulant drugs that inhibit thrombin (an enzy ...
JAN 11, 2021
Cell & Molecular Biology
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
JAN 11, 2021
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
Naturally occurring chemicals make more appealing medicines for many people, but there is not always evidence that they' ...
Loading Comments...